• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AP-1 和 Mitf 与 NFATc1 相互作用,刺激破骨细胞前体细胞中组织蛋白酶 K 启动子活性。

AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors.

机构信息

Division of Geriatrics and Palliative Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York.

Veterans Affairs Western New York Healthcare System Research Service, Buffalo, New York.

出版信息

J Cell Biochem. 2019 Aug;120(8):12382-12392. doi: 10.1002/jcb.28504. Epub 2019 Feb 28.

DOI:10.1002/jcb.28504
PMID:30816596
Abstract

Cathepsin K (CTSK) is a secreted protease that plays an essential role in osteoclastic bone resorption and osteoporotic bone loss. We have previously shown that activator protein 1 (AP-1) stimulates CTSK promoter activity and that proximal nuclear factor of activated T cells cytoplasmic 1 (NFATc1)-binding sites play a major role in the stimulation of CTSK gene expression by receptor activator of NFκB ligand (RANKL). In the present study, we have extended these observations and further dissected the effects of transcription factors involved in the regulation of CTSK gene expression. Our aim was to investigate the cooperative interplay among transcription factors AP-1, microphthalmia-associated transcription factor (Mitf), and NFATc1, and the consequent regulatory effects on CTSK transcription. Experiments were carried out in RAW 264.7 cells, which can be readily differentiated to osteoclasts upon RANKL stimulation. Our data show that AP-1, Mitf, and NFATc1 are capable of independently stimulating CTSK promoter activity. A combination of any two factors further enhances CTSK promoter activity, with the combination of AP-1 (c-fos/c-jun) and NFATc1 inducing the largest increase. We further identify a synergistic effect when all three factors cooperate intimately at the proximal promoter region, yielding maximal transcriptional upregulation of the CTSK promoter. RANKL induces temporal localization of AP-1 and NFATc1 to the CTSK promoter. These results suggest that the interaction of multiple transcription factors mediate a maximal response to RANKL-induced CTSK gene expression.

摘要

组织蛋白酶 K (CTSK) 是一种分泌性蛋白酶,在破骨细胞骨吸收和骨质疏松性骨丢失中发挥重要作用。我们之前已经表明,激活蛋白 1 (AP-1) 刺激 CTSK 启动子活性,并且近端核因子活化 T 细胞胞浆 1 (NFATc1) 结合位点在核因子κB 配体 (RANKL) 刺激 CTSK 基因表达中起主要作用。在本研究中,我们扩展了这些观察结果,并进一步剖析了参与 CTSK 基因表达调控的转录因子的作用。我们的目的是研究参与 CTSK 转录调控的转录因子 AP-1、小眼畸形相关转录因子 (Mitf) 和 NFATc1 之间的协同相互作用,以及对 CTSK 转录的相应调节作用。实验在 RAW 264.7 细胞中进行,这些细胞在受到 RANKL 刺激后很容易分化为破骨细胞。我们的数据表明,AP-1、Mitf 和 NFATc1 能够独立地刺激 CTSK 启动子活性。两种因子的组合进一步增强了 CTSK 启动子活性,而 AP-1 (c-fos/c-jun) 和 NFATc1 的组合诱导的增加最大。当所有三个因子在近端启动子区域密切合作时,我们进一步鉴定出协同作用,从而使 CTSK 启动子的转录最大程度地上调。RANKL 诱导 AP-1 和 NFATc1 在 CTSK 启动子上的时间定位。这些结果表明,多种转录因子的相互作用介导了对 RANKL 诱导的 CTSK 基因表达的最大反应。

相似文献

1
AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors.AP-1 和 Mitf 与 NFATc1 相互作用,刺激破骨细胞前体细胞中组织蛋白酶 K 启动子活性。
J Cell Biochem. 2019 Aug;120(8):12382-12392. doi: 10.1002/jcb.28504. Epub 2019 Feb 28.
2
Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.鉴定介导RANK配体刺激组织蛋白酶K启动子活性的NFAT结合位点。
Gene. 2009 Oct 15;446(2):90-8. doi: 10.1016/j.gene.2009.06.013. Epub 2009 Jun 27.
3
AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.AP-1在RAW 264.7细胞中刺激组织蛋白酶K启动子。
Gene. 2007 Nov 15;403(1-2):151-8. doi: 10.1016/j.gene.2007.08.007. Epub 2007 Aug 25.
4
Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.在RANKL诱导破骨细胞生成过程中,肌细胞增强因子2和小眼相关转录因子与NFATc1协同作用,反式激活V-ATP酶d2启动子。
J Biol Chem. 2009 May 22;284(21):14667-76. doi: 10.1074/jbc.M901670200. Epub 2009 Mar 25.
5
Enhanced osteoclastogenesis by mitochondrial retrograde signaling through transcriptional activation of the cathepsin K gene.通过组织蛋白酶K基因的转录激活,线粒体逆行信号增强破骨细胞生成。
Ann N Y Acad Sci. 2016 Jan;1364(1):52-61. doi: 10.1111/nyas.12709. Epub 2015 Mar 18.
6
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.咖啡酸 3,4-二羟基苯乙基酯通过抑制丝裂原活化蛋白激酶/激活蛋白 1 和 Ca2+-活化 T 细胞胞浆 1 信号通路抑制核因子 κB 配体诱导的破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
7
Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.小眼畸形-橡树岭突变小鼠破骨细胞中辅助激活因子募集缺陷
J Cell Physiol. 2009 Jul;220(1):230-7. doi: 10.1002/jcp.21755.
8
MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.在破骨细胞分化过程中,MITF和PU.1将p38丝裂原活化蛋白激酶(p38 MAPK)和活化T细胞核因子c1(NFATc1)招募至靶基因。
J Biol Chem. 2007 May 25;282(21):15921-9. doi: 10.1074/jbc.M609723200. Epub 2007 Apr 2.
9
Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.转化生长因子-β增强RANKL诱导的MITF-E表达及破骨细胞生成
Cell Biochem Funct. 2014 Jul;32(5):401-9. doi: 10.1002/cbf.3028. Epub 2014 Feb 12.
10
Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.白细胞介素-10部分通过抑制RAW264.7细胞和小鼠骨髓细胞中的c-Fos和c-Jun,来抑制RANKL介导的NFATc1表达。
Bone. 2007 Oct;41(4):592-602. doi: 10.1016/j.bone.2007.05.016. Epub 2007 Jun 13.

引用本文的文献

1
Skimmianine Attenuates Osteoclast Activity by Suppressing ERp57-Driven Calcium Oscillations/Calcineurin/Nfatc1 Signalling in Postmenopausal Osteoporosis.Skimmianine通过抑制绝经后骨质疏松症中ERp57驱动的钙振荡/钙调神经磷酸酶/Nfatc1信号传导来减弱破骨细胞活性。
J Cell Mol Med. 2025 Aug;29(15):e70777. doi: 10.1111/jcmm.70777.
2
Dusp1 in osteolytic diseases-mechanisms and therapeutic potential.双特异性磷酸酶1在溶骨性疾病中的作用机制及治疗潜力
Sci Rep. 2025 Jul 1;15(1):20887. doi: 10.1038/s41598-025-05142-6.
3
FABP4 inhibition suppresses bone resorption and protects against postmenopausal osteoporosis in ovariectomized mice.
脂肪酸结合蛋白4(FABP4)抑制可抑制去卵巢小鼠的骨吸收并预防绝经后骨质疏松症。
Nat Commun. 2025 May 13;16(1):4437. doi: 10.1038/s41467-025-59719-w.
4
LncRNAs modulating tooth development and alveolar resorption: Systematic review.调节牙齿发育和牙槽骨吸收的长链非编码RNA:系统评价
Heliyon. 2024 Oct 26;10(21):e39895. doi: 10.1016/j.heliyon.2024.e39895. eCollection 2024 Nov 15.
5
NAT10 promotes osteoclastogenesis in inflammatory bone loss by catalyzing Fos mRNA ac4C modification and upregulating MAPK signaling pathway.NAT10通过催化Fos mRNA的ac4C修饰并上调MAPK信号通路,促进炎症性骨质流失中的破骨细胞生成。
J Adv Res. 2025 Jun;72:303-317. doi: 10.1016/j.jare.2024.07.031. Epub 2024 Jul 31.
6
Functions of Epimedin C in a zebrafish model of glucocorticoid-induced osteoporosis.朝藿定 C 在糖皮质激素诱导的骨质疏松症斑马鱼模型中的作用。
J Cell Mol Med. 2024 Jul;28(14):e18569. doi: 10.1111/jcmm.18569.
7
NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling.维生素D和磷酸盐介导的骨细胞陷窝-小管重塑调节需要NFATc1
Endocrinology. 2024 Jul 1;165(8). doi: 10.1210/endocr/bqae087.
8
Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis.长链非编码 RNA Malat1 可预防骨质疏松症和骨转移。
Nat Commun. 2024 Mar 16;15(1):2384. doi: 10.1038/s41467-024-46602-3.
9
Emerging roles of MITF as a crucial regulator of immunity.MITF 作为免疫关键调节因子的新作用。
Exp Mol Med. 2024 Feb;56(2):311-318. doi: 10.1038/s12276-024-01175-5. Epub 2024 Feb 13.
10
Role and Regulation of Transcription Factors in Osteoclastogenesis.转录因子在破骨细胞分化中的作用与调控。
Int J Mol Sci. 2023 Nov 10;24(22):16175. doi: 10.3390/ijms242216175.